Zusammenfassung
Mutationen des Androgenrezeptorgens sind mit einem Spektrum von Störungen assoziiert, die von der kompletten Androgeninsensitivität mit weiblichem äußerem Genitale über die partielle Androgeninsensitivität mit intersexuellem Genitale bis zur minimalen Androgeninsensitivität mit männlicher Infertilität reichen. Das CAG-Repeat im 1. Exon ist für die Transaktivierung von Zielgenen bedeutsam und moduliert androgenabhängige Prozesse. Eine pathologische Expansion dieses Repeats verursacht die X-chromosomale spinobulbäre Muskelatrophie.
Abstract
Mutations of the androgen receptor gene cause a spectrum of androgen insensitivity phenotypes ranging from women with female external genitalia through patients with genital ambiguities to men with male genitalia but infertility. The CAG repeat in the first exon is important for transactivation of target genes of the androgen receptor and is thought to modulate androgen-dependent processes. Expansion of this repeat is the cause of X-linked spinobulbar muscular atrophy.
Literatur
Wieacker P, Griffin JE, Wienker T et al (1987) Linkage analysis with RFLPs in families with androgen resistance syndromes: evidence for close linkage between the androgen receptor locus and the segment DXS1. Hum Genet 76:248–252
Lubahn DB, Joseph DR, Sullivan PM et al (1988) Cloning of human androgen receptor complementary DNA and location to the X chromosome. Science 240:327–330
Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181–3188
Knoke I, Alléra A, Wieacker P (1999) Significance of the CAG repeat length of the androgen receptor gene (AR) for the transactivation function of an mutant M780I mutant AR. Hum Genet 104:257–261
Quigley CA, DeBellis A, Marschke KB et al (1995) Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 16:271–321
Rutgers JL, Scully RE (1991) The androgen insensitivity syndrome (testicular feminization): a clinicopathological study of 43 cases. Int J Gynecol Pathol 10:126–144
Han TS, Goswami D, Trikudanathan S et al (2008) Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur J Endocrinol 159:179–185
Hughes IA, Houk C, Ahmed SF, Lee PA (2006) Consensus statement on management of intersex disorders. J Ped Urol 2:148–162
Hurt WG, Bodurtha JN, McCall JB, Ali MM (1989) Seminoma in pubertal patient with androgen insensitivity syndrome. Am J Obstet Gynecol 161:530–531
Allera A, Herbst MA, Griffin JE et al (1995) Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. J Clin Endocrinol Metab 80:2697–2699
Wooster R, Mangion J, Ecles R et al (1992) A germ-line mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2:132–134
Lobaccaro JM, Lumbroso S, Belon C et al (1993) Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 2:1799–1802
Knoke I, Jakubiczka S, Lehnert H, Wieacker P (1999) Mutation of the androgen receptor gene in a patient with severe oligozoospermia. Andrologia 31:199–201
Yong EL, Ng SC, Roy AC et al (1994) Pregnancy after hormonal correction of severe spermatogenic defect due to a mutation in androgen receptor gene. Lancet 344:826–827
LaSpada AR, Roling DB, Harding AE et al (1992) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nat Genet 2:301–304
Wieacker P, Knoke I, Jakubiczka S (1998) Clinical and molecular aspects of androgen receptor defects. Exp Clin Endocrinol Diabetes 106:446–452
Gottlieb B, Beitel LK, Wu JH, Trifiro M (2004) The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 23:527–533
Rodien P, Mebarki F, Mowszowicz I et al (1996) Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 81:2994–2998
Krause A, Sinnecker GH, Hiort O et al (2004) Applicability of the SHBG androgen sensitivity test in the differential diagnosis of 46,XY gonadal dysgenesis, true hermaphroditism, and androgen insensitivity syndrome. Exp Clin Endocrinol Diabetes 112:236–240
Tut TG, Ghadessy FJ, Trifiro MA et al (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production and infertility. J Clin Endocrinol Metab 82:3777–3782
Pushek EE, Behzadian MA, McDonough PG (1994) The first analysis of exon 1 (the transactivation domain) of the androgen receptor gene in infertile men with oligospermia or azoospermia. Fertil Steril 62:1035–1038
Dadze S, Wieland C, Jakubiczka S et al (2000) The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoide sample of German origin. Mol Hum Reprod 6:207–214
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wieacker, P., Ledig, S. Androgeninsensitivität. medgen 23, 249–253 (2011). https://doi.org/10.1007/s11825-011-0275-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11825-011-0275-y
Schlüsselwörter
- Androgenrezeptor
- Androgeninsensitivität
- Männliche Infertilität
- Spinobulbäre Muskelatrophie
- Transaktivierung